PD-L1 (programmed cell death ligand 1, CD274) is a glycoprotein that controls the activity of the immune system by interacting with the PD-1 receptor on the surface of T cells, inducing apoptosis and inhibition, helping to inhibit the autoimmune response during the inflammation or anti-tumor response. This evidence concerns the gene CD274 and neoplasm.